|
|
||||||||
The Journal of Immunology, Vol 144, Issue 2 574-582, Copyright © 1990 by American Association of Immunologists
ARTICLES |
P Anderson, C Nagler-Anderson, C O'Brien, H Levine, S Watkins, HS Slayter, ML Blue and SF Schlossman
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115.
We have recently described a novel method for the production and characterization of mAb reactive with T cell-restricted intracellular antigens. From a panel of antibodies that react specifically with permeabilized T lymphocytes but not with permeabilized B lymphocytes or native T cells, we have selected one, designated TIA-1, that reacts with 20 to 36% of digitonin permeabilized peripheral blood T lymphocytes. Flow cytometric analysis of purified CD4+ and CD8+ subsets showed TIA-1 to recognize a subpopulation of 49 to 64% of CD8+ lymphocytes. Little or no reactivity with CD4+ resting T lymphocytes was observed. TIA-1 did not react with any of a panel of T cell lines, B cell lines, or monocytoid cell lines. TIA-1 reacted strongly with NK cell clones and CD8+ cytolytic T cell clones, and less strongly with CD4+-activated T cell clones, suggesting a preferential expression in cells possessing cytolytic potential. Cell fractionation experiments showed TIA-1 to be membrane associated. Furthermore, Percoll gradient fractionation of a cytolytic T cell clone (T4T8C1) showed the majority of TIA-1 to be contained in a low density membrane fraction that also contained serine protease activity. Immunoelectron microscopy showed TIA-1 to decorate the membranes of electron lucent and electron dense cytoplasmic granules in this same cytolytic T cell clone. Biochemical analysis showed TIA-1 to be a 15-kDa protein in unstimulated T cells. Upon activation with Con A or anti-CD3 antibodies. TIA-1 was induced to form disulfide linked dimers, trimers, and tetramers of the basic 15- kDa unit. Taken together, our data suggest that TIA-1 is a cytolytic granule associated protein that may define a subpopulation of resting CD8+ T lymphocytes possessing cytolytic potential.
This article has been cited by other articles:
![]() |
M. M. Emara, H. Liu, W. G. Davis, and M. A. Brinton Mutation of Mapped TIA-1/TIAR Binding Sites in the 3' Terminal Stem-Loop of West Nile Virus Minus-Strand RNA in an Infectious Clone Negatively Affects Genomic RNA Amplification J. Virol., November 1, 2008; 82(21): 10657 - 10670. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Faria, K. J. Gollob, J. Barbosa Jr, A. Schriefer, P. R. L. Machado, H. Lessa, L. P. Carvalho, M. A. Romano-Silva, A. R. de Jesus, E. M. Carvalho, et al. Decreased In Situ Expression of Interleukin-10 Receptor Is Correlated with the Exacerbated Inflammatory and Cytotoxic Responses Observed in Mucosal Leishmaniasis Infect. Immun., December 1, 2005; 73(12): 7853 - 7859. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pudney, A. J. Quayle, and D. J. Anderson Immunological Microenvironments in the Human Vagina and Cervix: Mediators of Cellular Immunity Are Concentrated in the Cervical Transformation Zone Biol Reprod, December 1, 2005; 73(6): 1253 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Alvaro, M. Lejeune, M. T. Salvado, R. Bosch, J. F. Garcia, J. Jaen, A. H. Banham, G. Roncador, C. Montalban, and M. A. Piris Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells Clin. Cancer Res., February 15, 2005; 11(4): 1467 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Zaunders, W. B. Dyer, B. Wang, M. L. Munier, M. Miranda-Saksena, R. Newton, J. Moore, C. R. Mackay, D. A. Cooper, N. K. Saksena, et al. Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection Blood, March 15, 2004; 103(6): 2238 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kaplan, F. A. Post, A. L. Moreira, H. Wainwright, B. N. Kreiswirth, M. Tanverdi, B. Mathema, S. V. Ramaswamy, G. Walther, L. M. Steyn, et al. Mycobacterium tuberculosis Growth at the Cavity Surface: a Microenvironment with Failed Immunity Infect. Immun., December 1, 2003; 71(12): 7099 - 7108. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Sadahira, K Notohara, and T Manabe Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules J. Clin. Pathol., August 1, 2003; 56(8): 631 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Steinhoff, M. Hummel, I. Anagnostopoulos, P. Kaudewitz, V. Seitz, C. Assaf, C. Sander, and H. Stein Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin Blood, June 28, 2002; 100(2): 578 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Morice, P. J. Kurtin, A. Tefferi, and C. A. Hanson Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B Blood, January 1, 2002; 99(1): 268 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Vermeer, R. van Doorn, D. Dukers, M. W. Bekkenk, C. J.L.M. Meijer, and R. Willemze CD8+ T Cells in Cutaneous T-Cell Lymphoma: Expression of Cytotoxic Proteins, Fas Ligand, and Killing Inhibitory Receptors and Their Relationship With Clinical Behavior J. Clin. Oncol., December 1, 2001; 19(23): 4322 - 4329. [Abstract] [Full Text] |
||||
![]() |
D F Dukers, M H Vermeer, L H Jaspars, C A Sander, M J Flaig, W Vos, R Willemze, and C J L M Meijer Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype J. Clin. Pathol., March 1, 2001; 54(3): 224 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mortarini, A. Borri, G. Tragni, I. Bersani, C. Vegetti, E. Bajetta, S. Pilotti, V. Cerundolo, and A. Anichini Peripheral Burst of Tumor-specific Cytotoxic T Lymphocytes and Infiltration of Metastatic Lesions by Memory CD8+ T Cells in Melanoma Patients Receiving Interleukin 12 Cancer Res., July 1, 2000; 60(13): 3559 - 3568. [Abstract] [Full Text] |
||||
![]() |
M. Guidoboni, C. Doglioni, L. Laurino, M. Boiocchi, and R. Dolcetti Activation of Infiltrating Cytotoxic T Lymphocytes and Lymphoma Cell Apoptotic Rates in Gastric MALT Lymphomas : Differences between High-Grade and Low-Grade Cases Am. J. Pathol., September 1, 1999; 155(3): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Berti, D. Tomasini, M. H Vermeer, C. J. Meijer, E. Alessi, and R. Willemze Primary Cutaneous CD8-Positive Epidermotropic Cytotoxic T Cell Lymphomas : A Distinct Clinicopathological Entity with an AggressiveClinical Behavior Am. J. Pathol., August 1, 1999; 155(2): 483 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dolcetti, A. Viel, C. Doglioni, A. Russo, M. Guidoboni, E. Capozzi, N. Vecchiato, E. Macri, M. Fornasarig, and M. Boiocchi High Prevalence of Activated Intraepithelial Cytotoxic T Lymphocytes and Increased Neoplastic Cell Apoptosis in Colorectal Carcinomas with Microsatellite Instability Am. J. Pathol., June 1, 1999; 154(6): 1805 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. ten Berge, D. F. Dukers, J. J. Oudejans, K. Pulford, G. J. Ossenkoppele, D. de Jong, J. F.M.M. Misere, and C. J.L.M. Meijer Adverse Effects of Activated Cytotoxic T Lymphocytes on the Clinical Outcome of Nodal Anaplastic Large Cell Lymphoma Blood, April 15, 1999; 93(8): 2688 - 2696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Vermeer, F. A.M.J. Geelen, J. A. Kummer, C. J.L.M. Meijer, and R. Willemze Expression of Cytotoxic Proteins by Neoplastic T Cells in Mycosis Fungoides Increases with Progression from Plaque Stage to Tumor Stage Disease Am. J. Pathol., April 1, 1999; 154(4): 1203 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Felgar, K. R. Steward, J. B. Cousar, and W. R. Macon T-Cell-Rich Large-B-Cell Lymphomas Contain Non-Activated CD8+ Cytolytic T Cells, Show Increased Tumor Cell Apoptosis, and Have Lower Bcl-2 Expression Than Diffuse Large-B-Cell Lymphomas Am. J. Pathol., December 1, 1998; 153(6): 1707 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Quayle, W. M. P. Coston, A. K. Trocha, S. A. Kalams, K. H. Mayer, and D. J. Anderson Detection of HIV-1-Specific CTLs in the Semen of HIV-Infected Individuals J. Immunol., October 15, 1998; 161(8): 4406 - 4410. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Altare, A. Durandy, D. Lammas, J. Emile, S. Lamhamedi, F. Le Deist, P. Drysdale, E. Jouanguy, R. Döffinger, F. Bernaudin, et al. Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency Science, May 29, 1998; 280(5368): 1432 - 1435. [Abstract] [Full Text] |
||||
![]() |
K. Tenner-Racz, H.-J. Stellbrink, J. van Lunzen, C. Schneider, J.-P. Jacobs, B. Raschdorff, G. Grossschupff, R. M. Steinman, and P. Racz The Unenlarged Lymph Nodes of HIV-1-infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy J. Exp. Med., March 16, 1998; 187(6): 949 - 959. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nakamura, E. Tatsumi, S. Kawano, A. Tani, S. Kumagai, M. Nishikori, and T. Nagai Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma of Natural Killer (NK) Lineage: Quest for Another NK-Lineage Neoplasm Blood, June 15, 1997; 89(12): 4665 - 4666. [Full Text] [PDF] |
||||
![]() |
Corrections for vol. 184, p. 1845 J. Exp. Med., March 17, 1997; 185(6): 1149 - 1150. [Full Text] [PDF] |
||||
![]() |
J.J. Oudejans, N.M. Jiwa, J.A. Kummer, G.J. Ossenkoppele, P. van Heerde, J.W. Baars, Ph.M. Kluin, J.C. Kluin-Nelemans, P.J. van Diest, J.M. Middeldorp, et al. Activated Cytotoxic T Cells as Prognostic Marker in Hodgkin's Disease Blood, February 15, 1997; 89(4): 1376 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Krenacs, A. Wellmann, L. Sorbara, A. W. Himmelmann, E. Bagdi, E. S. Jaffe, and M. Raffeld Cytotoxic Cell Antigen Expression in Anaplastic Large Cell Lymphomas of T- and Null-Cell Type and Hodgkin's Disease: Evidence for Distinct Cellular Origin Blood, February 1, 1997; 89(3): 980 - 989. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |